对于患者的移动健康解决方案:系统审查的协议
Pantea Keikhosrokiani1,2, Manria Polus1, Sharon Guardado Medina1
1Faculty of Information Technology and Electrical Engineering, University of Oulu, Oulu, Finland.
JMIR research protocols
|August 6, 2024
概括
本系统性审查评估了治疗的移动健康 (mHealth) 工具,评估了它们的有效性和患者的体验. 研究结果将指导开发用于管理的改进数字健康解决方案.
科学领域:
- 数字健康数字健康
- 症管理 症管理
- 移动健康 (mHealth) 解决方案
背景情况:
- 需要持续的治疗,以获得最佳的患者结果.
- 移动健康 (mHealth) 工具正在出现,以支持患者的治疗坚持.
- 现有的研究往往忽视了mHealth的有效性和医疗保健专业人员在数字护理中的角色.
研究的目的:
- 评估当前mHealth解决方案的有效性,以改善症药物坚持.
- 检查患者在病护理中使用mHealth工具的经验.
- 确定医疗保健专业人员在mHealth系统中的角色.
主要方法:
- 按照PRISMA指南进行系统的文献审查.
- 包括定性和定量分析.
- 专注于比较,分类和分析移动健康工具的有效性,患者体验和医疗保健专业人员角色.
主要成果:
- 在初始搜索,选和数据提取后,包括33篇论文.
- 预计该审查将于2024年10月完成.
- 预期的结果将详细介绍mHealth遵守工具的比较有效性和可用性.
结论:
- 针对的有效的mHealth解决方案应该是个性化的,包括药物管理,报警,追踪,咨询支持和更新的治疗计划.
- 这项研究旨在改善患者的mHealth解决方案.
- 结果将指导开发更高效和有效的未来mHealth系统用于管理.
相关概念视频
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Antiepileptic Drugs: Potassium Channel Activators
152
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
152
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
276
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
276
Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: Sodium Channel Blockers
472
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
472
Antiepileptic Drugs: Calcium Channel Blockers
350
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
350


